This grant, offered by DARPA, is for the purpose of developing a groundbreaking Wound Stasis System. The program aims to create materials-based agents and an effective delivery system capable of achieving targeted hemostasis and comprehensive wound control. This innovative solution must effectively treat all types of wounds, including compressible and non-compressible injuries, irrespective of their shape or location on the body. The ultimate goal is to produce a compact, hand-held device. This system is crucial for addressing critical military requirements by significantly improving blood loss control and enhancing wound outcomes for service members.
Opportunity ID: 46081
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-09-29 |
| Funding Opportunity Title: | Wound Stasis System (WSS) Program |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 17, 2009 |
| Last Updated Date: | May 06, 2009 |
| Original Closing Date for Applications: | Mar 16, 2010 |
| Current Closing Date for Applications: | Mar 16, 2010 |
| Archive Date: | Apr 16, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA seeks a materials-based agent(s) and delivery system that provides damaged tissue-targeted hemostasis and wound control capable of treating compressible and non-compressible wounds regardless of geometry and location. Successful completion will result in a hand-held delivery system that addresses military needs for control of blood loss and improved wound outcome.See attached DARPA-BAA-09-29 |
| Link to Additional Information: | DARPA-BAA-09-29 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
Email:DARPA-BAA-09-29@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modification 1 to DARPA-BAA-09-29 Wound Stasis System (WSS) is to revise Section IV – Application and Submission Information, Paragraph C.1 and C.2.
See attached modification. |
May 06, 2009 | |
| May 06, 2009 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-09-29 |
| Funding Opportunity Title: | Wound Stasis System (WSS) Program |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 17, 2009 |
| Last Updated Date: | May 06, 2009 |
| Original Closing Date for Applications: | Mar 16, 2010 |
| Current Closing Date for Applications: | Mar 16, 2010 |
| Archive Date: | Apr 16, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA seeks a materials-based agent(s) and delivery system that provides damaged tissue-targeted hemostasis and wound control capable of treating compressible and non-compressible wounds regardless of geometry and location. Successful completion will result in a hand-held delivery system that addresses military needs for control of blood loss and improved wound outcome.See attached DARPA-BAA-09-29 |
| Link to Additional Information: | DARPA-BAA-09-29 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
Email:DARPA-BAA-09-29@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-09-29 |
| Funding Opportunity Title: | Wound Stasis System (WSS) Program |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 06, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 16, 2010 |
| Archive Date: | Apr 16, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA seeks a materials-based agent(s) and delivery system that provides damaged tissue-targeted hemostasis and wound control capable of treating compressible and non-compressible wounds regardless of geometry and location. Successful completion will result in a hand-held delivery system that addresses military needs for control of blood loss and improved wound outcome.
See attached DARPA-BAA-09-29 |
| Link to Additional Information: | DARPA-BAA-09-29 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA Coordinator
Email:DARPA-BAA-09-29@darpa.mil |
Related Documents
Folder 46081 Full Announcement-1 -> DARPA-BAA-09-29 (WSS).pdf
Folder 46081 Revised Full Announcement-1 -> darpa-baa-09-29 modification 1.pdf
Packages
| Agency Contact Information: | BAA Coordinator Email: DARPA-BAA-09-29@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00011109 | Mar 17, 2009 | Mar 16, 2010 | View |
Package 1
Mandatory forms
46081 RR_SF424-1.1.pdf
Optional forms
46081 RR_FedNonFedBudget-1.1.pdf
46081 RR_FedNonFed_SubawardBudget-1.2.pdf
46081 RR_OtherProjectInfo-1.1.pdf
46081 RR_Budget-1.1.pdf
46081 RR_KeyPersonExpanded-1.1.pdf
46081 RR_PerformanceSite-1.1.pdf
46081 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
